Literature DB >> 29516194

Towards a better understanding of the many facets of attention-deficit/hyperactivity disorder.

Pieter J Hoekstra1.   

Abstract

Entities:  

Year:  2018        PMID： 29516194     DOI： 10.1007/s00787-018-1141-0

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  9 in total

1.  Multilevel analysis of ADHD, anxiety and depression symptoms aggregation in families.

Authors:  Daniel Segenreich; Marina Silva Paez; Maria Angélica Regalla; Dídia Fortes; Stephen V Faraone; Joseph Sergeant; Paulo Mattos
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-26       Impact factor: 4.785

2.  Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?

Authors:  Pieter J Hoekstra; Jan K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-04       Impact factor: 4.785

Review 3.  ADHD is associated with migraine: a systematic review and meta-analysis.

Authors:  Haitham Salem; David Vivas; Fei Cao; Iram F Kazimi; Antonio L Teixeira; Cristian P Zeni
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-09-13       Impact factor: 4.785

4.  Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan.

Authors:  Yin-To Liao; Yao-Hsu Yang; Ting-Yu Kuo; Hsin-Yi Liang; Kuo-You Huang; Tsu-Nai Wang; Yena Lee; Roger S McIntyre; Vincent Chin-Hung Chen
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-08-30       Impact factor: 4.785

5.  A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.

Authors:  Catherine Cornu; Catherine Mercier; Tiphanie Ginhoux; Sandrine Masson; Julie Mouchet; Patrice Nony; Behrouz Kassai; Valérie Laudy; Patrick Berquin; Nathalie Franc; Marie-France Le Heuzey; Hugues Desombre; Olivier Revol
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

6.  The impact of comorbid mental health symptoms and sex on sleep functioning in children with ADHD.

Authors:  Stephen P Becker; Caroline N Cusick; Craig A Sidol; Jeffery N Epstein; Leanne Tamm
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

7.  Clinical factors associated with decision to recommend methylphenidate treatment for children with ADHD in France.

Authors:  Elodie Courtabessis; Florence Pupier; Laurie Surig; Marie-Christine Picot; Erika Nogué; Valérie Macioce; Elizabeth Stein; Diane Purper-Ouakil
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

8.  Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder.

Authors:  Annabeth P Groenman; Jaap Oosterlaan; Nanda N J Rommelse; Barbara Franke; Corina U Greven; Pieter J Hoekstra; Catharina A Hartman; Marjolein Luman; Herbert Roeyers; Robert D Oades; Joseph A Sergeant; Jan K Buitelaar; Stephen V Faraone
Journal:  Br J Psychiatry       Date:  2013-07-11       Impact factor: 9.319

9.  Effectiveness of time-related interventions in children with ADHD aged 9-15 years: a randomized controlled study.

Authors:  Birgitta Wennberg; Gunnel Janeslätt; Anette Kjellberg; Per A Gustafsson
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-09-27       Impact factor: 4.785
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.